These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 27109490)

  • 1. Revisiting the Revolution: Examining the Evolving Role of Antiangiogenic Therapy in Cancer.
    Ebos JM; Quintela-Fandino M
    Curr Drug Targets; 2016; 17(15):1706. PubMed ID: 27109490
    [No Abstract]   [Full Text] [Related]  

  • 2. Antiangiogenic tumor therapy.
    Davis DW; McConkey DJ; Zhang W; Herbst RS
    Biotechniques; 2003 May; 34(5):1048-50, 1052, 1054 passim. PubMed ID: 12765031
    [No Abstract]   [Full Text] [Related]  

  • 3. Abstracts of the 1st European Conference on Tumor Angiogenesis and Antiangiogenic Therapy. Munich, Germany, 1-3 October 2004.
    Angiogenesis; 2004; 7 Suppl 1():1-53. PubMed ID: 15505925
    [No Abstract]   [Full Text] [Related]  

  • 4. Recognition of tumor blood vessel normalization as a new antiangiogenic concept.
    Hellmann K
    Nat Med; 2004 Apr; 10(4):329; author reply 329-30. PubMed ID: 15057218
    [No Abstract]   [Full Text] [Related]  

  • 5. Abstracts of the 2nd European Conference on Tumor Angiogenesis and Antiangiogenic Therapy (ECTA), 14-16 September 2006, Munich, Germany.
    Angiogenesis; 2006; 9 Suppl 1():1-35. PubMed ID: 16988901
    [No Abstract]   [Full Text] [Related]  

  • 6. Natural compounds show antiangiogenic activity.
    Marwick C
    J Natl Cancer Inst; 2001 Nov; 93(22):1685. PubMed ID: 11717328
    [No Abstract]   [Full Text] [Related]  

  • 7. [Angiogenesis and antiangiogenic cancer therapy].
    Pour L; Hájek R; Buchler T; Maisnar V; Smolej L
    Vnitr Lek; 2004 Dec; 50(12):930-8. PubMed ID: 15717808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Angiogenesis in cancer].
    Pozner RG; Negrotto S; Schattner M
    Medicina (B Aires); 2002; 62(6):604-6. PubMed ID: 12532700
    [No Abstract]   [Full Text] [Related]  

  • 9. Aberrant tumor vasculature and angiogenesis: new opportunities for cancer therapy.
    Zhu Z
    Drug Discov Today; 2003 Sep; 8(18):827-8. PubMed ID: 12963316
    [No Abstract]   [Full Text] [Related]  

  • 10. Current state of knowledge regarding the use of antiangiogenic agents with radiation therapy.
    Mazeron R; Anderson B; Supiot S; Paris F; Deutsch E
    Cancer Treat Rev; 2011 Oct; 37(6):476-86. PubMed ID: 21546163
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monitoring responses to antiangiogenic agents using noninvasive imaging tests.
    Libutti SK; Choyke P; Carrasquillo JA; Bacharach S; Neumann RD
    Cancer J Sci Am; 1999; 5(5):252-6. PubMed ID: 10526663
    [No Abstract]   [Full Text] [Related]  

  • 12. Therapeutic targeting of the tumor vasculature.
    Tozer GM; Bicknell R
    Semin Radiat Oncol; 2004 Jul; 14(3):222-32. PubMed ID: 15254865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antiangiogenic therapy: Markers of response, "normalization" and resistance.
    El Alaoui-Lasmaili K; Faivre B
    Crit Rev Oncol Hematol; 2018 Aug; 128():118-129. PubMed ID: 29958627
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Angiogenesis inhibitors in combinatorial approaches.
    Nowak-Sliwinska P; Griffioen AW
    Angiogenesis; 2017 May; 20(2):183-184. PubMed ID: 28382510
    [No Abstract]   [Full Text] [Related]  

  • 15. Tumor Angiogenesis: A Key Target for Cancer Therapy.
    Marmé D
    Oncol Res Treat; 2018; 41(4):164. PubMed ID: 29587285
    [No Abstract]   [Full Text] [Related]  

  • 16. Challenges facing antiangiogenic therapy for cancer: impact of the tumor extracellular environment.
    Gagne P; Akalu A; Brooks PC
    Expert Rev Anticancer Ther; 2004 Feb; 4(1):129-40. PubMed ID: 14748663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug resistance associated with antiangiogenesis therapy.
    Eikesdal HP; Kalluri R
    Semin Cancer Biol; 2009 Oct; 19(5):310-7. PubMed ID: 19524042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Angiogenesis: a target for cancer therapy.
    Tortora G; Melisi D; Ciardiello F
    Curr Pharm Des; 2004; 10(1):11-26. PubMed ID: 14754402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antiangiogenic strategies and agents in clinical trials.
    Rosen L
    Oncologist; 2000; 5 Suppl 1():20-7. PubMed ID: 10804087
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of antiangiogenic and antivascular therapeutics using MRI: recommendations for appropriate methodology for clinical trials.
    Leach MO; Brindle KM; Evelhoch JL; Griffiths JR; Horsman MR; Jackson A; Jayson G; Judson IR; Knopp MV; Maxwell RJ; McIntyre D; Padhani AR; Price P; Rathbone R; Rustin G; Tofts PS; Tozer GM; Vennart W; Waterton JC; Williams SR; Workman P
    Br J Radiol; 2003; 76 Spec No 1():S87-91. PubMed ID: 15456718
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.